Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Board appointment at Light Sciences Oncology

This article was originally published in Scrip

Executive Summary

Light Sciences Oncology (US) has elected Dr Frank Young to a newly created seat on its board of directors. He held positions in clinical practice, academia and government, including Commissioner of the FDA from 1984 to 1989. Dr Young is presently a partner at Essex Woodlands Health Ventures, an investor in Light Sciences Oncology.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC031494

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel